Bailey was indeed a very special part of our family and knowing that he received such excellent care from such a wonderful group of people has made this difficult time for us more bearable.
Treatments that may be used in place of or in conjunction with standard therapies may be recommended. On such alternative therapy is called Polysaccharopeptide (PSP), which is the bioactive agent from the mushroom Coriolus versicolor. These mushrooms have been used in traditional Chinese medicine for more than 2,000 years and studies indicate PSP has in vitro anti-tumor activities and inhibits the growth of tumors in animal studies.
A recent small study published by University of Pennsylvania researchers evaluated a mushroom extract in a small number of dogs with naturally occurring hemangiosarcoma, an aggressive, invasive cancer that arises from the blood cells and typically affects the spleen. Patients in the study received the mushroom extract as the sole therapy without surgery. Results suggested the mushroom extract was helpful in fighting the tumors. Further investigations on a larger scale are currently underway. We are currently evaluating this compound in a variety of cancers in conjunction with standard therapies. Hope Veterinary Specialists Oncology Service will be collaborating with the Veterinary Clinical Investigations Center at the Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania in Philadelphia in a clinical trial evaluating dogs with hemangiosarcoma treated with either: the mushroom extract alone, the mushroom extract in combination with chemotherapy, or chemotherapy alone. Hope Veterinary Specialists will be the only center outside of the University of Pennsylvania participating in the trial.